Industry News Center
Explore the latest news, product knowledge and industry insights in the GLP-1 field to
support your business growth and professional development
support your business growth and professional development
Vetion Tirzepatide Injection Achieves WHO Prequalification Milestone, Accelerating Global Access to Affordable GLP-1 Therapy
August 27, 2025 – Vetion Pharmaceuticals, a pioneer in metabolic disease therapeutics, announces that its Tirzepatide injection has entered the World Health Organization (WHO) International ...
Read More →
2023 International Diabetes Congress: GLP-1 Drugs Become Research Focus
At the recently concluded 2023 International Diabetes Congress, GLP-1 receptor agonists (GLP-1 RAs) emerged as the central theme, with experts and scholars highlighting their transformative ...
Read More →
Correct Usage and Precautions for Semaglutide Injection
Semaglutide injection is a GLP-1 receptor agonist widely used for type 2 diabetes management and chronic weight loss. As a wholesale supplier of GLP-1 drugs, ...
Read More →
Vetion Semaglutide Oral Tablets Obtain Thai FDA Marketing Authorization
Vetion® Semaglutide Oral Tablets Obtain Thai FDA Marketing Authorization, Expanding Global Access to Affordable GLP-1 Therapy August 26, 2025 – Vetion Pharmaceuticals, a leader in ...
Read More →
2023 GLP-1 Drug Market Report: Global Scale to Exceed $20 Billion
August 26, 2023 – The latest industry research report shows that the GLP-1 drug market is growing at an average annual rate of 35%, and ...
Read More →
Vetion’s New Factory Officially Put into Production, Annual Capacity Increased to 50 Million Units
November 15, 2023 – Vetion, a leading innovator in metabolic therapeutics, has officially launched its state-of-the-art GLP-1 drug production base in Laos, significantly boosting its ...
Read More →
Vetion’s New Factory Officially Put into Production, Annual Capacity Increased to 50 Million Units
November 15, 2023 – Vetion, a leading innovator in metabolic therapeutics, has officially launched its state-of-the-art GLP-1 drug production base in Laos, significantly boosting its ...
Read More →
2023 GLP-1 Drug Market Report: Global Scale to Exceed $20 Billion
August 26, 2023 – The latest industry research report shows that the GLP-1 drug market is growing at an average annual rate of 35%, and ...
Read More →
2023 International Diabetes Congress: GLP-1 Drugs Become Research Focus
At the recently concluded 2023 International Diabetes Congress, GLP-1 receptor agonists (GLP-1 RAs) emerged as the central theme, with experts and scholars highlighting their transformative ...
Read More →
Vetion Semaglutide Oral Tablets Obtain Thai FDA Marketing Authorization
Vetion® Semaglutide Oral Tablets Obtain Thai FDA Marketing Authorization, Expanding Global Access to Affordable GLP-1 Therapy August 26, 2025 – Vetion Pharmaceuticals, a leader in ...
Read More →
Vetion Tirzepatide Injection Achieves WHO Prequalification Milestone, Accelerating Global Access to Affordable GLP-1 Therapy
August 27, 2025 – Vetion Pharmaceuticals, a pioneer in metabolic disease therapeutics, announces that its Tirzepatide injection has entered the World Health Organization (WHO) International ...
Read More →
Correct Usage and Precautions for Semaglutide Injection
Semaglutide injection is a GLP-1 receptor agonist widely used for type 2 diabetes management and chronic weight loss. As a wholesale supplier of GLP-1 drugs, ...
Read More →
Global Investment Cooperation
Seeking Pharmaceutical & Healthcare Partners Worldwide · Time-Sensitive Policy with Milestone
Incentives Available
Incentives Available
National-level Pharmaceutical Agents
Large Medical Institutions
Pharmaceutical E-commerce
Platforms
Distribution Platforms
Big Health Industry
Need More Wholesale Information? Contact Our Wholesale Team
Our professional wholesale team will provide you with customized procurement plans,preferential wholesale prices, and comprehensive market support services!